β-Cyclodextrin/thermosensitive containing polymer brushes grafted onto magnetite nano-particles for extraction and determination of venlafaxine in biological and pharmaceutical samples

International Journal of Pharmaceutics

Volumn 476, Issue 1, 2014, Pages 178-184

  Ahmad Panahi, Homayon ^a   Alaei, Haniyeh Sadat ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Antidepressant; Biological samples; Drug delivery; Magnetite nano particles; Pharmaceutical samples; Solid phase extraction; Venlafaxine

Indexed keywords

BETA CYCLODEXTRIN; MAGNETITE NANOPARTICLE; POLYMER; POLY[BETA CYCLODEXTRIN CO N ISOPROPYLACRYLAMIDE]; UNCLASSIFIED DRUG; VENLAFAXINE; (3-MERCAPTOPROPYL)TRIMETHOXYSILANE; ACRYLAMIDE DERIVATIVE; ALLYLAMINE; BETA CYCLODEXTRIN DERIVATIVE; CYCLOHEXANOL DERIVATIVE; N-ISOPROPYLACRYLAMIDE; SEROTONIN UPTAKE INHIBITOR; SILANE DERIVATIVE;

ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG ISOLATION; DRUG RELEASE; FINITE ELEMENT ANALYSIS; HEAT SENSITIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFRARED SPECTROSCOPY; PH; POLYMERIZATION; SCANNING ELECTRON MICROSCOPY; TEMPERATURE; THERMOGRAVIMETRY; TRANSMISSION ELECTRON MICROSCOPY; URINALYSIS; ADSORPTION; CHEMISTRY; FEASIBILITY STUDY; TIME;

ACRYLAMIDES; ADSORPTION; ALLYLAMINE; BETA-CYCLODEXTRINS; CYCLOHEXANOLS; FEASIBILITY STUDIES; HUMANS; HYDROGEN-ION CONCENTRATION; MAGNETITE NANOPARTICLES; POLYMERS; SEROTONIN UPTAKE INHIBITORS; SILANES; TEMPERATURE; TIME FACTORS;

EID: 84907904960     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.09.051     Document Type: Article

References (32)

1. O. Attoui Yahia, and D.E. Khatmi Theoretical study of the inclusion processes of venlafaxine with β-cyclodextrin J. Mol. Struct. Theochem. 912 2009 38 43
2. A.Z.M. Badruddoza, G.S.S. Hazel, K. Hidajat, and M.S. Uddin Synthesis of carboxymethyl-β-cyclodextrin conjugated magnetic nano-adsorbent for removal of methylene blue Colloids Surf. A 367 2010 85 95
3. J. Bhatt, A. Jangid, G. Venkatesh, G. Subbaiah, and S. Singh Liquid chromatography-tandem mass spectrometry (LC-MS-MS) method for simultaneous determination of venlafaxine and its active metabolite O-desmethyl venlafaxine in human plasma J. Chromatogr. B 829 2005 75 81
4. G. Bia, C.P. De Pauli, and L. Borgnino The role of Fe(III) modified montmorillonite on fluoride mobility: adsorption experiments and competition with phosphate J. Environ. Manage. 100 2012 1 9
5. B.J. Boyd Past and future evolution in colloidal drug delivery systems Exp. Opin. Drug Deliv. 5 2008 69 85
6. S.P. Chavan, S. Garai, and K.P. Pawar Asymmetric total synthesis of (-)-venlafaxine using an organocatalyst Tetrahedron Lett. 54 2013 2137 2139
7. S. Haquea, S. Md, M. Fazil, M. Kumar, J. Kaur Sahni, J. Ali, and S. Baboota Venlafaxine loaded chitosan NPs for brain targeting pharmacokinetic and pharmacodynamic evaluation Carbohydr. Polym. 89 2012 72 79
8. D.R. Hicks, D. Wolaniuk, A. Russell, N. Cavanaugh, and M. Kraml A high performance liquid chromatographic method for the simultaneous determination of venlafaxine and O-desmethylvenlafaxine in biological fluids Ther. Drug Monit. 16 1994 100 107
9. M. Iijima, and H. Kamiya Surface modification for improving the stability of nano-particles in liquid media J. Phys. Chem. C 112 2008 11786 11790
10. W. Liu, F. Wang, and H.D. Li Simultaneous stereoselective analysis of venlafaxine and O-desmethylvenlafaxine enantiomers in human plasma by HPLC-ESI/MS using a vancomycin chiral column J. Chromatogr. B 850 2007 183 189
11. S.N. Makhija, and P.R. Vavia Stability indicating LC method for the estimation of venlafaxine in pharmaceutical formulations J. Pharm. Biomed. Anal. 28 2002 1055 1059
12. R. Mandrioli, L. Mercolini, R. Cesta, S. Fanali, M. Amore, and M.A. Raggi Analysis of the second generation antidepressant venlafaxine and its main active metabolite O-desmethylvenlafaxine in human plasma by HPLC with spectrofluorimetric detection J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 856 2007 88 94
13. O. Mastrogianni, G. Theodoridis, K. Spagou, D. Violante, T. Henriques, A. Pouliopoulos, K. Psaroulis, H. Tsoukali, and N. Raikos Determination of venlafaxine in post-mortem whole blood by HS-SPME and GC-NPD Forensic Sci. Int. 215 2012 105 109
14. M. Matoga, F. Pehourcq, K. Titier, F. Dumora, and C. Jarry Rapid high-performance liquid chromatographic measurement of venlafaxine and O-desmethylvenlafaxine in human plasma. Application to management of acute intoxications J. Chromatogr. B 760 2001 213 218
15. E.A. Muth, J.T. Haskins, J.A. Moyer, G.E. Husbands, S.T. Nielsen, and E.B. Sigg Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative Biochem. Pharmacol. 35 1986 4493 4497
16. S.V. Otton, S.E. Ball, S.W. Cheung, T. Inaba, R.L. Rudolph, and E.M. Sellers Venlafaxine oxidation in vitro is catalysed by CYP2D6 Br. J. Clin. Pharmacol. 41 1996 149 156
17. B.N. Patel, N. Sharma, M. Sanyal, and P.S. Shrivastav Liquid chromatography tandem mass spectrometry assay for the simultaneous determination of venlafaxine and O-desmethylvenlafaxine in human plasma and its application to a bioequivalence study J. Pharm. Biomed. Anal. 47 2008 603 611
18. H.A. Patel, S. Shah, D.O. Shah, and P.A. Joshi Sustained release of venlafaxine from venlafaxine-montmorillonite-polyvinylpyrrolidone composites J. Appl. Clay Sci. 51 2011 126 130
19. F.T. Peters Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology Clin. Biochem. 44 2011 54 65
20. A. Pich, S. Bhattacharya, A. Ghosh, and H.J.P. Adler Composite magnetic particles: 2. Encapsulation of iron oxide by surfactant-free emulsion polymerization Polymer 46 2005 4596 4603
21. F. Qin, N. Li, T. Qin, Y. Zhang, and F. Li Simultaneous quantification of venlafaxine and O-desmethylvenlafaxine in human plasma by ultra performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study J. Chromatogr. B 878 2010 689 694
22. M.M. Rahman, M.M. Chehimi, H. Fessi, and A. Elaissari Highly temperature responsive core-shell magnetic particles: synthesis, characterization and colloidal properties J. Colloid Interface Sci. 360 2011 556 564
23. S. Rudaz, C. Stella, A.E. Balant-Gorgia, S. Fanali, and J.L. Veuthey Simultaneous stereoselective analysis of venlafaxine and O-desmethylvenlafaxine enantiomers in clinical samples by capillary electrophoresis using charged cyclodextrins J. Pharm. Biomed. Anal. 23 2000 107 115
24. C. Sun, J.S.H. Lee, and M. Zhang Magnetic nanoparticles in MR imaging and drug delivery Adv. Drug Deliv. Rev. 60 2008 1252 1265
25. G. Theodoridis, A. Kantifes, P. Manesiotis, N. Raikos, and T.P. Heleni Preparation of a molecularly imprinted polymer for the solid-phase extraction of scopolamine with hyoscyamine as a dummy template molecule J. Chromatogr. A 987 2003 103 109
26. V.P. Torchilin Multifunctional nanocarriers Adv. Drug Deliv. Rev. 58 2006 1532 1555
27. T. Weber, and R. Chakravorti Pore and solid diffusion models for fixed bed adsorbent J. Am. Inst. Chem. Eng. 2 1974 228 238
28. A.D. Wilson, C. Howell, and W.S. Waring Venlafaxine ingestion is associated with rhabdomyolysis in adults: a case series J. Toxicol. Sci. 32 2007 97 101
29. S.M. Wille, P. Van Hee, H.M. Neels, C.H. Van Peteghem, and W.E. Lambert Comparison of electron and chemical ionization modes by validation of a quantitative gas chromatographic-mass spectrometric assay of new generation antidepressants and their active metabolites in plasma J. Chromatogr. A 1176 2007 236 245
30. X. Yang Qin, J. Meng, X. Ye Li, J. Zhou, X. Li Sun, and A. Dong Wen Determination of venlafaxine in human plasma by high-performance liquid chromatography using cloud-point extraction and spectrofluorimetric detection J. Chromatogr. B 872 2008 38 42
31. Y. Ye, Y. Sun, H. Zhao, M. Lan, F. Gao, C. Song, K. Lou, H. Li, and W. Wang A novel lactoferrin-modified β-cyclodextrin nanocarrier for brain-targeting drug delivery Int. J. Pharm. 458 2013 110 117
32. Y. Zu, Y. Zhang, X. Zhao, C. Shan, S. Zu, K. Wang, Y. Li, and Y. Ge Preparation and characterization of chitosan-polyvinyl alcohol blend hydrogels for the controlled release of nano-insulin Int. J. Biol. Macromol. 50 2012 82 87